Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
460-03-004 ISMRM Abstract

Using Magnetic Resonance Imaging and Pathological Characteristics in Predicting PD-L1 Level in Patients with Breast Cancer

Primary: Diffusion - IVIM
Secondary: Diffusion - DWI/DTI/DKI
460-03-004 · Image Classification for Breast Cancer · Tuesday, 12 May, 1:40 PM–2:35 PM · Digital Posters Row A
Accepted
Yiwen Wang , Weiwei Wang1, Xiuzheng Yue2, Zhiyuan He1,3, Zhanguo Sun1,4
1Department of Medical Imaging, Affiliated Hospital of Jining Medical University, Jining, China
2Clinical and Technical Support, Philips Healthcare (Beijing), Beijing, China
3Jining Medical College, Jining, China
4Department of Radiology, Affiliated Hospital of Jining Medical University, Jining, China
Presenting Author: Yiwen Wang

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Lin J, Fang W, Xiang Z et al (2023) Glycolytic enzyme HK2 promotes PD-L1 expression and breast cancer cell immune evasion. Front Immunol 14:1189953
2. M. Morrow, J. Waters and E. Morris, “MRI for breast cancer screening, diagnosis, and treatment,” Lancet 9805 (2011): 1804-1811.

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/460-03-004